J. F. Enten

J. F. Enten

Auto-generated profile, based on publicly available information

J. F. Enten

Flow Cytometry Shared Resource, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL 33136

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NKN. J. Kapolka
N. J. Kapolka
GTG. J. Taghon
G. J. Taghon
JRJ. B. Rowe
J. B. Rowe
WMW. M. Morgan
W. M. Morgan
JEJ. F. Enten
J. F. Enten
DIDaniel G. Isom
Daniel G. Isom
Significance: G protein-coupled receptors (GPCRs) are the largest class of membrane receptors in humans. As such, GPCR signaling is central to human biology and medicine. While more than 30% of approved drugs target roughly 150 GPCRs, most receptors lack well-defined endogenous ligands and are currently not druggable. To address this challenge, we created DCyFIR, a GPCR screening platform for ligand and drug discovery. This technology enables the cost-effective profiling of ligands and drug compounds against mixtures of hundreds of GPCR-barcoded cell strains in a single experiment. Because ligands are tested against many receptors simultaneously, DCyFIR profiling will eventually enable the physical screening of huge numbers of compounds, bringing wet-laboratory experimental throughput a step closer to what is done in silico.